{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:18:50Z","timestamp":1791256730442,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/leu.2014.78","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T07:42:10Z","timestamp":1392882130000},"page":"1819-1827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"28","author":[{"given":"C","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Roderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"LaBelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Bodaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Pyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K E","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L B","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Sallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Bradner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L D","family":"Walensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Kelliher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-9007","authenticated-orcid":false,"given":"A","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"BFleu201478_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","volume":"114","author":"A Gutierrez","year":"2009","unstructured":"Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009; 114: 647\u2013650.","journal-title":"Blood"},{"key":"BFleu201478_CR2","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","volume":"28","author":"A Gutierrez","year":"2010","unstructured":"Gutierrez A, Dahlberg SE, Neuberg DS, Zhang J, Grebliunaite R, Sanda T et al. Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia. J Clin Oncol 2010; 28: 3816\u20133823.","journal-title":"J Clin Oncol"},{"key":"BFleu201478_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu201478_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, JPt Morris, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu201478_CR5","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1128\/MCB.01091-06","volume":"26","author":"VM Sharma","year":"2006","unstructured":"Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 2006; 26: 8022\u20138031.","journal-title":"Mol Cell Biol"},{"key":"BFleu201478_CR6","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261\u201318266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201478_CR7","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gad.1450406","volume":"20","author":"AP Weng","year":"2006","unstructured":"Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma. Genes Dev 2006; 20: 2096\u20132109.","journal-title":"Genes Dev"},{"key":"BFleu201478_CR8","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood.V84.12.4038.bloodjournal84124038","volume":"84","author":"J Hebert","year":"1994","unstructured":"Hebert J, Cayuela JM, Berkeley J, Sigaux F . Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994; 84: 4038\u20134044.","journal-title":"Blood"},{"key":"BFleu201478_CR9","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Van Vlierberghe","year":"2012","unstructured":"Van Vlierberghe P, Ferrando A . The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398\u20133406.","journal-title":"J Clin Invest"},{"key":"BFleu201478_CR10","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20101691","volume":"208","author":"A Gutierrez","year":"2011","unstructured":"Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu S, Guo F et al. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med 2011; 208: 1595\u20131603.","journal-title":"J Exp Med"},{"key":"BFleu201478_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203\u20131210.","journal-title":"Nat Med"},{"key":"BFleu201478_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2012.02.029","volume":"21","author":"PS Subramaniam","year":"2012","unstructured":"Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K et al. Targeting nonclassical oncogenes for therapy in T-ALL. Cancer Cell 2012; 21: 459\u2013472.","journal-title":"Cancer Cell"},{"key":"BFleu201478_CR13","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/415922a","volume":"415","author":"P Bouillet","year":"2002","unstructured":"Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922\u2013926.","journal-title":"Nature"},{"key":"BFleu201478_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735\u20131738.","journal-title":"Science"},{"key":"BFleu201478_CR15","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.1073\/pnas.0914878107","volume":"107","author":"JA Ryan","year":"2010","unstructured":"Ryan JA, Brunelle JK, Letai A . Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes. Proc Natl Acad Sci USA 2010; 107: 12895\u201312900.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl","key":"BFleu201478_CR16","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0092-8674(02)00675-X","volume":"109","author":"CH Bassing","year":"2002","unstructured":"Bassing CH, Swat W, Alt FW . The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002; 109 (Suppl): S45\u2013S55.","journal-title":"Cell"},{"key":"BFleu201478_CR17","first-page":"91","volume":"1","author":"C Viret","year":"1999","unstructured":"Viret C, Janeway CA Jr. . MHC and T cell development. Rev Immunogenet 1999; 1: 91\u2013104.","journal-title":"Rev Immunogenet"},{"key":"BFleu201478_CR18","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1182\/blood-2004-08-3073","volume":"105","author":"DM Langenau","year":"2005","unstructured":"Langenau DM, Jette C, Berghmans S, Palomero T, Kanki JP, Kutok JL et al. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 2005; 105: 3278\u20133285.","journal-title":"Blood"},{"key":"BFleu201478_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ng896","volume":"31","author":"G Golling","year":"2002","unstructured":"Golling G, Amsterdam A, Sun Z, Antonelli M, Maldonado E, Chen W et al. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 2002; 31: 135\u2013140.","journal-title":"Nat Genet"},{"key":"BFleu201478_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O et al. Selective inhibition of BET bromodomains. Nature 2010; 468: 1067\u20131073.","journal-title":"Nature"},{"key":"BFleu201478_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","volume":"18","author":"K Rakhra","year":"2010","unstructured":"Rakhra K, Bachireddy P, Zabuawala T, Zeiser R, Xu L, Kopelman A et al. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 2010; 18: 485\u2013498.","journal-title":"Cancer Cell"},{"key":"BFleu201478_CR22","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1182\/blood-2009-07-234377","volume":"115","author":"A Gutierrez","year":"2010","unstructured":"Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S et al. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood 2010; 115: 2845\u20132851.","journal-title":"Blood"},{"key":"BFleu201478_CR23","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O'Neil","year":"2007","unstructured":"O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813\u20131824.","journal-title":"J Exp Med"},{"key":"BFleu201478_CR24","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1172\/JCI46231","volume":"122","author":"JL LaBelle","year":"2012","unstructured":"LaBelle JL, Katz SG, Bird GH, Gavathiotis E, Stewart ML, Lawrence C et al. A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. J Clin Invest 2012; 122: 2018\u20132031.","journal-title":"J Clin Invest"},{"key":"BFleu201478_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/emboj\/19.5.989","volume":"19","author":"J Nakae","year":"2000","unstructured":"Nakae J, Barr V, Accili D . Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 2000; 19: 989\u2013996.","journal-title":"EMBO J"},{"key":"BFleu201478_CR26","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1200\/JCO.2011.37.0981","volume":"30","author":"MS Davids","year":"2012","unstructured":"Davids MS, Letai A . Targeting the B-cell lymphoma\/leukemia 2 family in cancer. J Clin Oncol 2012; 30: 3127\u20133135.","journal-title":"J Clin Oncol"},{"key":"BFleu201478_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/cdd.2008.42","volume":"15","author":"CA Jette","year":"2008","unstructured":"Jette CA, Flanagan AM, Ryan J, Pyati UJ, Carbonneau S, Stewart RA et al. BIM and other BCL-2 family proteins exhibit cross-species conservation of function between zebrafish and mammals. Cell Death Differ 2008; 15: 1063\u20131072.","journal-title":"Cell Death Differ"},{"key":"BFleu201478_CR28","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","volume":"7","author":"SM Maira","year":"2008","unstructured":"Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008; 7: 1851\u20131863.","journal-title":"Mol Cancer Ther"},{"key":"BFleu201478_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011; 146: 904\u2013917.","journal-title":"Cell"},{"key":"BFleu201478_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","volume":"10","author":"G Wei","year":"2006","unstructured":"Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006; 10: 331\u2013342.","journal-title":"Cancer Cell"},{"key":"BFleu201478_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","volume":"21","author":"U Maurer","year":"2006","unstructured":"Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR . Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006; 21: 749\u2013760.","journal-title":"Mol Cell"},{"key":"BFleu201478_CR32","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC . AKT\/PKB signaling: navigating downstream. Cell 2007; 129: 1261\u20131274.","journal-title":"Cell"},{"key":"BFleu201478_CR33","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.4049\/jimmunol.168.10.5024","volume":"168","author":"M Stahl","year":"2002","unstructured":"Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002; 168: 5024\u20135031.","journal-title":"J Immunol"},{"key":"BFleu201478_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O'Donnell","year":"2005","unstructured":"O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839\u2013843.","journal-title":"Nature"},{"key":"BFleu201478_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/ncb2037","volume":"12","author":"KJ Mavrakis","year":"2010","unstructured":"Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010; 12: 372\u2013379.","journal-title":"Nat Cell Biol"},{"key":"BFleu201478_CR36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature07396","volume":"455","author":"E Gavathiotis","year":"2008","unstructured":"Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG et al. BAX activation is initiated at a novel interaction site. Nature 2008; 455: 1076\u20131081.","journal-title":"Nature"},{"key":"BFleu201478_CR37","doi-asserted-by":"publisher","first-page":"D48","DOI":"10.1093\/nar\/gks1236","volume":"41","author":"P Flicek","year":"2013","unstructured":"Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S et al. Ensembl 2013. Nucleic Acids Res 2013; 41: D48\u2013D55.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201478_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O'Connor","year":"1998","unstructured":"O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17: 384\u2013395.","journal-title":"EMBO J"},{"key":"BFleu201478_CR39","first-page":"2976","volume":"62","author":"JW Liu","year":"2002","unstructured":"Liu JW, Chandra D, Tang SH, Chopra D, Tang DG . Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim. Cancer Res 2002; 62: 2976\u20132981.","journal-title":"Cancer Res"},{"key":"BFleu201478_CR40","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1128\/MCB.22.11.3577-3589.2002","volume":"22","author":"M Marani","year":"2002","unstructured":"Marani M, Tenev T, Hancock D, Downward J, Lemoine NR . Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 2002; 22: 3577\u20133589.","journal-title":"Mol Cell Biol"},{"key":"BFleu201478_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature03845","volume":"436","author":"MT Hemann","year":"2005","unstructured":"Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436: 807\u2013811.","journal-title":"Nature"},{"key":"BFleu201478_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc1954","volume":"6","author":"CJ Sherr","year":"2006","unstructured":"Sherr CJ . Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6: 663\u2013673.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201478_CR43","unstructured":"Gutierrez A, Feng H, Stevenson K, Neuberg DS, Calzada O, Zhou Y et al. Loss of function tp53 mutations do not accelerate the onset of Myc-induced T-ALL in the zebrafish. Br J Haematol, (in press)."},{"key":"BFleu201478_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.1206727","volume":"334","author":"TN Chonghaile","year":"2011","unstructured":"Chonghaile TN, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore VD et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011; 334: 1129\u20131133.","journal-title":"Science"},{"key":"BFleu201478_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","volume":"12","author":"J Deng","year":"2007","unstructured":"Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A . BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007; 12: 171\u2013185.","journal-title":"Cancer Cell"},{"key":"BFleu201478_CR46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2012.08.038","volume":"151","author":"TT Vo","year":"2012","unstructured":"Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM et al. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 2012; 151: 344\u2013355.","journal-title":"Cell"},{"key":"BFleu201478_CR47","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1182\/blood-2010-05-284968","volume":"116","author":"PS Bachmann","year":"2010","unstructured":"Bachmann PS, Piazza RG, Janes ME, Wong NC, Davies C, Mogavero A et al. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition. Blood 2010; 116: 3013\u20133022.","journal-title":"Blood"},{"key":"BFleu201478_CR48","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1182\/blood-2010-04-280818","volume":"116","author":"L Happo","year":"2010","unstructured":"Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ et al. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. Blood 2010; 116: 5256\u20135267.","journal-title":"Blood"},{"key":"BFleu201478_CR49","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1182\/blood-2010-02-268003","volume":"116","author":"JA Richter-Larrea","year":"2010","unstructured":"Richter-Larrea JA, Robles EF, Fresquet V, Beltran E, Rullan AJ, Agirre X et al. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood 2010; 116: 2531\u20132542.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201478","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:21:48Z","timestamp":1648743708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFleu201478"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.78","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]},"assertion":[{"value":"23 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LDW is a scientific advisory board member and consultant for Aileron Therapeutics. The Dana-Farber Cancer Institute has filed patents on and licensed drug-like derivatives of JQ1 to Tensha Therapeutics for clinical translation as cancer therapeutics. JEB and the Dana-Farber Cancer Institute have been granted equity (minority) in Tensha, and JEB serves on the Board of Directors. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}